Does RAS Status Increase the Prevalence of Positive Resection Margin in Colorectal Liver Metastasis? A Systematic Review and Meta-Analysis

Background Colorectal liver metastasis has a high incidence, and RAS oncogene mutation status carries significant prognostic information. We aimed to assess whether RAS-mutated patients present more or less frequently with positive margins in their hepatic metastasectomy. Methods We performed a syst...

Full description

Saved in:
Bibliographic Details
Published in:The American surgeon 2023-12, Vol.89 (12), p.5638-5647
Main Authors: Brandão, Gabriela Rangel, Trindade, Bruna Oliveira, Flores, Luís Henrique Fernandes, Motter, Sarah Bueno, Alves, Cassio Bona, Remonti, Tiago Auatt Paes, Lucchese, Angélica Maria, Junior, Antonio Dal Pizzol, Kalil, Antonio Nocchi
Format: Article
Language:English
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Colorectal liver metastasis has a high incidence, and RAS oncogene mutation status carries significant prognostic information. We aimed to assess whether RAS-mutated patients present more or less frequently with positive margins in their hepatic metastasectomy. Methods We performed a systematic review and meta-analysis of studies from PubMed, Embase, and Lilacs databases. We analyzed liver metastatic colorectal cancer studies, which included information on RAS status and had surgical margin analysis of the liver metastasis. Odds ratios were computed using a random-effect model due to anticipated heterogeneity. We further performed a subanalysis limited to studies that included only patients with KRAS instead of all-RAS mutations. Results From the 2,705 studies screened, 19 articles were included in the meta-analysis. There were 7,391 patients. The prevalence of positive resection margin was not significantly different between patients carrier vs non-carrier for the all-RAS mutations (OR .99; 95% CI 0.83-1.18; P = .87), and for only KRAS mutation (OR .93; 95% CI 0.73-1.19; P = .57). Conclusions Despite the strong correlation between colorectal liver metastasis prognosis and RAS mutation status, our meta-analysis’s results suggest no correlation between the RAS status and the prevalence of positive resection margins. The findings contribute to a better understanding of the RAS mutation’s role in the surgical resections of colorectal liver metastasis. Graphical Abstract
ISSN:0003-1348
1555-9823
DOI:10.1177/00031348231156763